The Next Big Thing In Biotech: Worst CEO Candidates
Nov 23, 2012 | 5:00 AM EST - 

Adam Feuerstein, Sr. Columnist for TheStreet, is assembling candidates for the Worst Biotech CEO of 2012 award.

Columnist Conversations

Anyone have a line on which MLP fund blew up because it seems to have finished its selling
While some still hope the Fed will hold on interest rates because of the difficult external environment, other...
The utilities were the outperforming sector in today's decidedly dismal market. The Utilities Select Sector SP...
$1.6 billion to sell market on close.

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.